Khalil Chaïbi
Khalil Chaïbi is an expert in Critical care at Hôpital Avicenne (France). Khalil Chaïbi has authored 52 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 2 of them ongoing. SLR score: 327 (community average: 125). How the SLR is computed.
LeadR Profile
Critical care
Subspecialties: Infectiology - Nephrology - Pulmonology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2016 - 2026
Number : 52
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Intermittent or Continuous Renal-Replacement Therapy in Acute Kidney Injury. PMID 42873070 — continuous renal replacement therapy, mortality, kidney, respect, critical illness, therapeutics, renal replacement therapy, acute kidney injury | N Engl J Med Top journal | 2026 | 0 |
| AKI in Severe Legionnaires' Disease in Intensive Care Unit. PMID 42751414 — proteinuria, mortality, incidence, legionella, kidney, legionnaires' disease, therapeutics, intensive care units, rhabdomyolysis, prognosis | Kidney Int Rep | 2026 | 0 |
| The UNDERSCORE for RRT weaning prediction: promising but not yet ready to unplug. Author's reply. PMID 41984149 — critical care, intensive care units, weaning | Intensive Care Med | 2026 | 0 |
| Predictive factors of successful renal replacement therapy weaning : Deciding On patients Orientations after Renal replacement therapy Stopping (The DOORS study). PMID 41843064 — critical care, therapeutics, intensive care units, renal replacement therapy, weaning | Intensive Care Med | 2026 | 0 |
| Prognosis of critically ill patients with severe acute kidney injury and high circulating dipeptidyl peptidase 3: a post hoc analysis of the AKIKI 2 trial. PMID 41776654 — kidney, critical illness, peptide hydrolases, acute kidney injury, prognosis | Crit Care | 2026 | 0 |
Clinical Studies 6
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Acute Kidney Injury Long term Renal and Cardiovascular Prognosis and Biomarker based Risk Assessment NCT07596407 — incidence, fibrosis, risk assessment, kidney, biomarkers, kidney failure, chronic, acute kidney injury, prognosis | N/A | Not yet recruiting | 2026 |
| Antimicrobial Therapy for Difficult to treat Pseudomonas Aeruginosa NCT06738771 — pseudomonas infections, pharmaceutical preparations, drug resistance, multiple, cohort studies, pseudomonas, drug resistance, multiple, bacterial, pseudomonas aeruginosa, beta-lactams, therapeutics, anti-bacterial agents, prognosis, infections, lactams, drug resistance | N/A | Recruiting | 2025 |
LeadR Networks
Main global connection map